Global Ganja Report

Small is Beautiful for the Berkshires’ Badass Bud

Nestled in the Berkshire Mountains of western Massachusetts is the town of West Stockbridge, where Wiseacre Farm boasts that it is the smallest artisanal cannabis producer in the commonwealth.

Irradiated cannabis? Yes, it’s a reality. While it may sound scary, industry tells us not to worry. Consumer advocacy groups, however, are raising concerns.

The cannabis industry is globalizing fast, which means changes for mainstays of commercial production in Europe and North America, and new players coming on line from regions such as the Middle East, Southeast Asia and Central America. Here’s a brief overview of a few entries from these categories.

The National Football League has awarded a $1 million research grant to study the impacts of cannabinoids on pain management and neuroprotection in football players. The move represents a breakthrough given the NFL's longstanding zero-tolerance stance on cannabis use.

With political and legal space opening for cannabis in state after state, a backlash is manifesting in the idea of caps on the potency—whether of bud, extracts or edibles. Voices from the industry and activist community see this as a throwback to the days of Reefer Madness.

California has finally taken a step to resolve the ambiguities and inconsistencies in the regulation of hemp-derived CBD — a move that could see the state setting a de facto national standard in light of continued inaction by the US Food & Drug Administration.

New York's new Gov. Kathy Hochul is hyping the coming cannabis boom in the state — although no adult-use licenses have yet been issued, and the bureaucracy is just starting to move on this. Meanwhile, the cops in Gotham City are turning a blind eye to small outfits that are setting up tables in the parks and on the sidewalks, selling edibles, extracts and bud. How long will this utopian free-for-all last?

As political and legal space opens for cannabis in state after state, the idea of caps on the potency — whether of flower, extracts or edibles — is gaining currency. But voices in the cannabis industry view this as a phobic response rooted in the flawed assumptions of prohibition.